| Literature DB >> 17922765 |
Delphine Pagès1, Lisa Sanchez, Sandrine Conrod, Xavier Gidrol, Agnes Fekete, Philippe Schmitt-Kopplin, Thierry Heulin, Wafa Achouak.
Abstract
Pseudomonas brassicacearum forms phenotypic variants in vitro as well as in planta during root colonization under natural conditions, leading to subpopulations (phase I and II cells) that differ in colony morphology and production of exoenzymes/secondary metabolites. The maximal concentration of cadmium allowing both variants growth was 25 muM; however, phase II cells accumulated fivefold higher Cd than phase I cells, even though both variants showed the same growth rate and kinetics, comprising a long stasis period (50 h). The whole transcriptome analysis of both variants in response to Cd was investigated using the home-made DNA microarrays. This analysis revealed completely different adaptation mechanisms developed by each variant to withstand and grow in the presence of the toxic. A re-organization of the cell wall to limit Cd entrance was noticed for phase I cells, as genes encoding levan exopolymers were downregulated at the expense of an upregulation of genes encoding alginate, and an upregulation of transporters such as cadA, and a downregulation of copper transporters. Phase II cells were unable to prevent Cd entrance and recruited genes under the control of oxyR and soxR regulation to face osmotic and oxidant stresses generated by Cd. Putrescine and spermidine metabolism appeared to play a central role in Cd tolerance. Microarray data were validated by biological analyses such as motility, oxidative stress assay, metabolite profiling with ICR-FT/MS and UPLC, capillary electrophoresis analysis of biogenic amines.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17922765 PMCID: PMC2121137 DOI: 10.1111/j.1462-2920.2007.01394.x
Source DB: PubMed Journal: Environ Microbiol ISSN: 1462-2912 Impact factor: 5.491
Fig. 1Growth of P. brassicacearum phase I and II cells in the presence or absence of the maximal tolerated Cd dose (25 μM).
Results of microarray analysis.
| Fold change | ||
|---|---|---|
| I | II | |
| Carbohydrate metabolism | ||
| | ||
| | ||
| 63F9 PEPC (pyruvate metabolism) | 0.37 ± 0.09 | |
| | ||
| 119F9 3-Hexulose 6-phosphate synthase | 2.82 ± 0.24 | |
| 46F3 Starvation-sensing protein RspA (galactose metabolism) | 2.28 ± 0.36 | |
| 86G3 Acetate CoA ligase (pyruvate metabolism) | 2.30 ± 0.84 | |
| 82H3 iolC protein (inositol metabolism) | 3.87 ± 2.61 | |
| 20G10 Iron-containing alcohol dehydrogenase (galactose metabolism) | 2.40 ± 0.75 | |
| | ||
| 43B5 Sorbitol dehydrogenase | 0.45 ± 0.08 | |
| 84D4 Polysaccharide deacetylase (amino sugar metabolism) | 0.49 ± 0.07 | |
| 16G9 Quinoprotein glucose dehydrogenase (pentose phosphate pathway) | 2.37 ± 0.40 | 4.61 ± 0.58 |
| 58C8 Acetyl CoA carboxylase | 0.40 ± 0.13 | 0.53 ± 0.09 |
| 10A10 Acetyl CoA ligase | 0.32 ± 0.19 | 0.50 ± 0.06 |
| Energy metabolism (oxidative phosphorylation) | ||
| 18H6 NADH quinone oxidoreductase, B subunit | 0.40 ± 0.05 | |
| 5E6 cbb3-type cytochrome oxidase | 0.49 ± 0.10 | |
| 15F9 NADH quinone oxidoreductase, subunit 5 | 2.41 ± 0.37 | 4.56 ± 0.66 |
| 15G9 Cytochrome B561 | 2.62 ± 0.62 | 5.80 ± 0.70 |
| 13D7 Electron transfer flavoprotein, beta subunit | 0.52 ± 0.09 | 0.49 ± 0.03 |
| Lipid metabolism | ||
| 24D6 Glycerophosphoryl diester phosphodiesterase | 2.40 ± 0.21 | |
| 64C8 3-Hydroxyacyl-CoA dehydrogenase | 0.48 ± 0.05 | |
| 94D4 Enoyl CoA hydratase/carnithine racemase | 0.46 ± 0.13 | |
| | ||
| | ||
| 14B6 3-Ketoacyl-CoA thiolase | 0.44 ± 0.19 | 0.46 ± 0.07 |
| 38F10 Acyl CoA dehydrogenase | 0.39 ± 0.21 | 0.50 ± 0.16 |
| 34F7 Short-chain dehydrogenase/reductase SDR | 3.10 ± 1.75 | 4.46 ± 1.70 |
| Purine metabolism | ||
| 3A11 GMP reductase | 0.26 ± 0.23 | |
| Amino acid metabolism | ||
| 10D12 Glucosamine-fructose 6-phosphate aminotranferase | 2.21 ± 0.65 | |
| 28E2 Glucosamine 6-phosphate synthetase | 2.05 ± 0.08 | |
| 9C4 Threonyl-tRNA synthetase | 2.50 ± 0.47 | |
| 71E5 3-Methylcrotonyl-CoA carboxylase, beta subunit | 0.28 ± 0.27 | |
| 17A8 Arginine deiminase | 0.39 ± 0.09 | |
| | ||
| | ||
| | ||
| 15B2 Diaminopimelate epimerase | 2.36 ± 0.28 | |
| 34B12 Glutamate dehydrogenase/leucine dehydrogenase | 2.27 ± 0.73 | |
| | ||
| | ||
| | ||
| | ||
| 37C4 76C5 7C10 Glutamine synthetase | 0.30 ± 0.08 | |
| 74B11 Predicted glutamine amidotransferase | 0.31 ± 0.10 | |
| | ||
| 16H8 Homogentisate 1,2-dioxygenase | 0.28 ± 0.21 | |
| 22A8 4-Hydroxyphenylpyruvate dioxygenase | 0.46 ± 0.08 | |
| 77A6 Anthranilate/para-benzoate synthase | 0.46 ± 0.12 | |
| 100B10 Dihydropicolinate synthase | 0.31 ± 0.11 | |
| 54C2 Zn-dependent dipeptidase | 0.38 ± 0.04 | |
| 14C8 Glutamyl- and glutaminyl-tRNA synthetase | 0.30 ± 0.07 | 0.23 ± 0.06 |
| | ||
| 84E7 NAD-glutamate dehydrogenase | 0.34 ± 0.06 | 0.24 ± 0.02 |
| 76E2 Threonine synthase | 0.49 ± 0.08 | 0.45 ± 0.03 |
| 16B9 Glycine dehydrogenase | 0.32 ± 0.20 | 0.39 ± 0.14 |
| 21A11 Succinyl arginine dehydrolase | 0.21 ± 0.08 | 0.14 ± 0.01 |
| 24B6 Succinyl arginine dehydrolase | 0.37 ± 0.05 | 0.37 ± 0.07 |
| 19H2 NAD-dependent aldehyde dehydrogenase | 0.24 ± 0.04 | 0.26 ± 0.03 |
| 20F2 NAD-dependent aldehyde dehydrogenase | 0.22 ± 0.11 | 0.23 ± 0.07 |
| | 0.47 ± 0.04 | 0.39 ± 0.24 |
| Cell wall | ||
| | ||
| 105D11 Pilus assembly protein, major pilin A | 2.52 ± 0.47 | |
| 2H7 Predicted periplasmic/secreted protein | 0.16 ± 0.15 | |
| 112A3 Peptidase U32 family | 0.43 ± 0.20 | |
| | ||
| | ||
| | ||
| 104D1 PHA synthase I | 0.45 ± 0.20 | |
| 21G1 Calcium-binding outer membrane-like protein | 0.49 ± 0.07 | |
| 15H10 Binding protein-dependent transport system inner membrane | 0.48 ± 0.11 | |
| | ||
| 42G6 Sucrose 6-phosphate hydrolase (starch and sucrose metabolism) | 0.32 ± 0.17 | |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| 12F10 Levansucrase (starch and sucrose metabolism) | 0.30 ± 0.03 | 0.39 ± 0.06 |
| Transporters | ||
| 7C12 Pyrimidine nucleoside transporter | 7.76 ± 3.90 | |
| 31A1 ABC transporter like | 2.25 ± 0.85 | |
| 32H6 ABC-type spermidine/putrescine transport system | 3.07 ± 1.60 | |
| | ||
| | ||
| 33H6 TonB | 2.20 ± 0.40 | |
| 45E8 13E8 Mannitol transporter, periplasmic binding protein | 0.33 ± 0.13 | |
| 29B3 Putative cyanate transporter | 0.26 ± 0.02 | |
| | ||
| 33G5 15B11 Predicted permease | 2.24 ± 0.20 | |
| 77D6 Permease MFS | 3.20 ± 0.48 | |
| 72C6 Predicted Na+-dependent transporter | 2.16 ± 0.56 | |
| | ||
| | ||
| 63D7 43F5 spermidine/putrescine-binding periplasmic protein | 2.20 ± 0.70 | |
| | ||
| 32F5 Permease MFS | 0.30 ± 0.08 | |
| 62B12 Dipeptide ABC transporter, periplasmic peptide-binding component | 0.47 ± 0.04 | |
| 23E6 ABC transporter-like, periplasmic component | 0.22 ± 0.13 | |
| 2D4 ABC-type sugar transport system | 0.50 ± 0.12 | |
| 32G11 Amino acid ABC transporter | 0.46 ± 0.13 | |
| 12B5 Amino acid ABC transporter | 0.31 ± 0.15 | |
| 95D3 Amino acid ABC transporter | 0.49 ± 0.05 | |
| 48F9 Amino acid ABC transporter | 0.49 ± 0.12 | |
| 84E6 Amino acid ABC transporter | 0.48 ± 0.13 | |
| TRAP-type C4-dicarboxylate transport system | 0.48 ± 0.11 | |
| | ||
| | ||
| | ||
| | ||
| 73G3 General substrate transporter, TonB box | 0.46 ± 0.08 | |
| 79E8 OmpA family protein | 0.42 ± 0.23 | |
| | ||
| 42E6 ABC-type metal ion transport system | 2.11 ± 0.55 | 2.71 ± 0.44 |
| | ||
| | ||
| 15E9 Formate/nitrite transporter family | 2.13 ± 0.16 | 3.45 ± 0.63 |
| 134D10 ABC transporter, permease protein | 0.37 ± 0.17 | 0.36 ± 0.12 |
| 59H9 ABC transporter, periplasmic peptide-binding protein | 0.19 ± 0.11 | 0.11 ± 0.01 |
| 4E5 ABC-type histidine transport system | 0.54 ± 0.05 | 0.49 ± 0.09 |
| 75A9 ABC-type nitrate/sulfonate/bicarbonate transport system | 0.40 ± 0.12 | 0.33 ± 0.06 |
| 67F10 79E9 13C8 ABC transporter, periplasmic component | 0.31 ± 0.10 | 0.26 ± 0.05 |
| 24F5 ABC transporter, periplasmic component | 0.29 ± 0.07 | 0.12 ± 0.05 |
| 23H8 39G3 ABC transporter, periplasmic component | 0.37 ± 0.03 | 0.21 ± 0.14 |
| 78C4 ABC transporter, probable binding protein component | 0.13 ± 0.06 | 0.16 ± 0.07 |
| 45E2 Major facilitator family transporter | 0.25 ± 0.10 | 0.33 ± 0.05 |
| 4B10 83G1 96A5 Permease of the MFS | 0.32 ± 0.08 | 0.43 ± 0.09 |
| 74B7102A11 Permease of the MFS | 0.22 ± 0.15 | 0.14 ± 0.05 |
| 113A2 Probable porin | 0.24 ± 0.07 | 0.24 ± 0.02 |
| | ||
| Secondary metabolites biosynthesis | ||
| | ||
| | ||
| | ||
| 31C4 Polyketide synthase | 0.40 ± 0.1 | |
| Stress-related genes | ||
| | ||
| | ||
| | ||
| 113A8 Selenocysteine lyase | 2.98 ± 1.48 | |
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| Iron-related genes | ||
| 13A11 Pyoverdine synthetase A | 0.49 ± 0.12 | |
| 19H6 4Fe-4S ferredoxin, iron-sulfur binding | 0.37 ± 0.08 | |
| 10D2 Polyferredoxin | 2.55 ± 0.21 | |
| 51H9 Isochorismatase family protein | 0.43 ± 0.08 | |
| Regulators | ||
| 126C1 DNA-binding response regulator, LuxR family | 2.34 ± 0.82 | |
| 67B8 Putative sensor protein RstB | 2.81 ± 0.74 | |
| 5F8 Histidine kinase colS | 2.00 ± 0.50 | |
| 133G4 Transcriptional regulator PcaQ | 0.47 ± 0.12 | |
| 10C11 Transcriptional regulator LysR family | 0.34 ± 0.11 | |
| 13A10 Putative transcriptional regulator | 0.44 ± 0.14 | |
| 120C8 RpoC | 3.57 ± 1.20 | |
| 45C12 Response regulator containing CheY-like receiver | 3.15 ± 1.14 | |
| 34F8 Sensor histidine kinase/response regulator | 3.02 ± 0.95 | |
| | ||
| 114A4 Transcriptional regulator MerR family | 2.04 ± 0.54 | |
| 94G12 Transcriptional regulator AraC family | 0.48 ± 0.10 | |
| 17H6 Sensory box histidine kinase PAS/PAC domain | 0.41 ± 0.12 | |
| 24D7 GGDEF domain | 0.49 ± 0.14 | |
| 75C3 Two-component response regulator | 2.46 ± 0.51 | 4.02 ± 1.18 |
| 112C7 Sigma-54-dependent transcriptional regulator | 0.30 ± 0.09 | 0.45 ± 0.10 |
| Genetic information processing | ||
| 5C1 Ribosomal protein S1 | 2.11 ± 0.35 | |
| 2OD2 HupN histone-like protein | 2.04 ± 0.34 | |
| 7H12 DNA dependent DNA polymerase, beta chain | 3.36 ± 2.02 | |
| 21C2 30S ribosomal protein S11 | 0.50 ± 0.10 | |
| 23D12 Putative DNA methyltransferase | 0.40 ± 0.03 | |
| 73H9 Cell division protein FtsL | 3.02 ± 1.04 | |
| 16E6 Translation initiation factor IF-1 | 2.46 ± 0.86 | |
| 82D9 Putative transposase TnpG | 2.57 ± 0.54 | |
| 119F7 Ribosome modulation factor | 2.17 ± 0.50 | |
| 45D1 Ribonuclease HI | 0.5 ± 0.04 | |
| 81A11 S1 RNA-binding domain protein | 0.48 ± 0.10 | |
| 17F1 GyrB type II topoisomerase, beta subunit | 0.4 ± 0.12 | |
| 45H1 Translation elongation factor G | 2.56 ± 0.57 | 2.45 ± 0.73 |
| 23F1 Topoisomerase IA | 0.46 ± 0.08 | 0.43 ± 0.12 |
| | ||
| 110F1 Putative DNA repair protein RadA | 2.87 ± 0.91 | 0.36 ± 0.26 |
| Unknown function | ||
| 54B8 Rhs element Vgr protein | 0.39 ± 0.06 | |
| 68E11 Predicted aminopeptidase | 0.28 ± 0.01 | |
| 15B4 Aerobic-type carbon monoxide dehydrogenase, CoxL/CutL homologue | 2.99 ± 0.41 | |
| 108E7 Probable protease | 2.17 ± 0.78 | |
| 34A9 Protozoan/cyanobacterial globin family protein | 2.16 ± 0.59 | |
| 33C2 Predicted membrane protein | 2.78 ± 1.00 | |
| 131E4 15G11 GTP-binding protein EngB | 2.7 ± 0.75 | |
| 133F11 Amidase | 0.36 ± 0.06 | |
| 108D10 fmtB-like protein | 0.38 ± 0.13 | |
| 28F10 Mu-like prophage tail sheath protein gpL | 0.38 ± 0.05 | |
| 32F7 Predicted membrane protein | 21.93 ± 9.82 | 92.66 ± 28.65 |
| 33C6 Phage-related protein | 12.91 ± 3.80 | 33.35 ± 14.50 |
| 86C3 Penicillin amidase V | 2.71 ± 0.80 | 3.09 ± 0.79 |
| 72G4 Putative membrane protein | 0.35 ± 0.16 | 0.32 ± 0.11 |
| 77 E7 Putative ATP/GTP-binding protein | 0.49 ± 0.13 | 0.40 ± 0.09 |
| 100F9 Uncharacterized protein homologue of lactam utilization | 0.11 ± 0.01 | 0.18 ± 0.05 |
| 9D3 PspB homologue (serine protease) | 0.31 ± 0.10 | 0.35 ± 0.05 |
| No homology | ||
| 84G2 No homology | 3.47 ± 0.40 | |
| 5D12 No homology | 2.10 ± 0.41 | |
| 79B10 No homology | 0.49 ± 0.07 | |
| 73E8 No homology | 0.46 ± 0.14 | |
| 71B6 No homology | 0.49 ± 0.14 | |
| 27D12 No homology | 0.40 ± 0.17 | |
| 108F6 No homology | 2.84 ± 1.53 | |
| 21D3 No homology | 0.42 ± 0.12 | |
| 68H2 No homology | 0.27 ± 0.03 | |
| 29E6 No homology | 0.24 ± 0.04 | |
| 23F2 No homology | 0.49 ± 0.13 | 0.43 ± 0.19 |
| 81B3 No homology | 0.41 ± 0.11 | 0.44 ± 0.15 |
| 26E9 No homology | 0.45 ± 0.11 | 0.50 ± 0.05 |
| 30C4 No homology | 0.48 ± 0.14 | 0.47 ± 0.09 |
| Hypothetical proteins | ||
| 73F9 Unknown protein | 4.31 ± 0.96 | |
| 77F4 Unknown protein | 3.61 ± 1.25 | |
| 38E6 Unknown protein | 2.77 ± 0.34 | |
| 76E8 Conserved hypothetical protein | 2.46 ± 0.59 | |
| 38E1 Hypothetical protein | 2.27 ± 0.20 | |
| 17D11 Unknown protein | 0.47 ± 0.09 | |
| 19F8 Unknown protein | 0.43 ± 0.17 | |
| 49A7 Unknown protein | 0.48 ± 0.09 | |
| 84A10 Conserved hypothetical protein | 0.44 ± 0.14 | |
| 16D8 Hypothetical protein | 0.32 ± 0.12 | |
| 16B2 Hypothetical protein | 0.48 ± 0.13 | |
| 55D1 Hypothetical protein | 0.45 ± 0.08 | |
| 75E6 Hypothetical protein | 0.41 ± 0.08 | |
| 76F7 Hypothetical protein | 0.48 ± 0.12 | |
| 90A3 Hypothetical protein | 0.43 ± 0.22 | |
| 2C9 Unknown protein | 3.44 ± 1.17 | |
| 34H9 Conserved hypothetical protein | 3.12 ± 1.15 | |
| 36B10 Unknown protein | 3.07 ± 0.82 | |
| 53G10 Hypothetical protein | 2.93 ± 1.38 | |
| 55E9 Hypothetical protein | 2.51 ± 0.78 | |
| 133E2 Unknown protein | 2.38 ± 0.87 | |
| 28D9 Hypothetical protein | 2.25 ± 0.45 | |
| 59D5 Hypothetical protein | 2.18 ± 0.56 | |
| 15H9 Hypothetical protein | 2.08 ± 0.60 | |
| 97D3 Unknown protein | 0.32 ± 0.07 | |
| 56D2 Hypothetical protein | 0.47 ± 0.14 | |
| 11F5 Hypothetical protein | 2.31 ± 0.71 | 2.54 ± 1.02 |
| 45A12 Hypothetical protein | 3.75 ± 2.30 | 3.20 ± 1.09 |
| 74G8 Hypothetical protein | 2.00 ± 0.38 | 2.74 ± 1.19 |
| 20F7 Hypothetical protein | 10.85 ± 3.75 | 13.34 ± 4.96 |
| 17C6 Hypothetical protein | 10.11 ± 3.33 | 11.41 ± 2.80 |
| 73H11 Unknown protein | 2.30 ± 0.73 | 3.55 ± 1.08 |
| 131C9 Unknown protein | 8.27 ± 2.81 | 14.68 ± 5.20 |
| 13C10 Hypothetical protein | 0.40 ± 0.08 | 0.49 ± 0.13 |
| 89F1 Conserved hypothetical protein | 0.44 ± 0.13 | 0.30 ± 0.07 |
| 20F4 Conserved hypothetical protein | 0.29 ± 0.14 | 0.33 ± 0.10 |
| 18A2 Conserved hypothetical protein | 0.36 ± 0.04 | 0.24 ± 0.03 |
| 106A9 Hypothetical protein | 2.27 ± 0.50 | 0.48 ± 0.10 |
Fold change (P < 0.05) is indicated for original phase (I) and the corresponding variant phase (II) cells. This factor is a mean of the different hybridization experiments. The codes in the first column are the clone numbers. Lines in bold indicate genes discussed in this article.
Fig. 2Overview of cadmium response in original phase I cells (black) and the corresponding variant phase II cells (grey). Genes selected by microarray analysis and specifically regulated by each bacterial phase were sequenced and classified according to their putative function. The horizontal axis represents the percentage of genes modulated by Cd.
Fig. 3Identification of two operons involved in PHL synthesis (phl operon) and putrescine uptake (pot operon), respectively, upregulated (red) in phase I cells and downregulated (green) in phase II cells in response to heavy metal toxicity. The ratios of gene expression obtained in the microarray analysis are indicated for each clone. A thin bar represents each cloned DNA fragment.
Fig. 4Expression analysis by semi-quantitative RT-PCR of cadA, lvs, alg8, phlA, B, C, D, potF1 and potF2 genes. Amplification signals of cDNA from phase I or II cells, cultivated with or without added CdCl2, were quantified and normalized using the control gene.
Fig. 5ICR-FT/MS of the four extracts (phase I and II with and without CdCl2) in replicates with the simulated spectrum of DAPG showing the various isotopes used for elemental composition confirmation.
Oxidative stress tolerance of P. brassicacearum NFM421: sensitivities to H2O2 and to methyl viologen were evaluated on agar plates of bacteria pre-cultivated in the presence or absence of CdCl2 (25 μM) by measuring the size of inhibition halo (in cm).
| Oxidative sensitivity | ||||
|---|---|---|---|---|
| H2O2 tolerance | Paraquat tolerance | |||
| Cd concentration in culture medium | I | II | I | II |
| 0 | 3.2 ± 0.44 | 3.6 ± 0.35 | 3.2 ± 0.01 | 3.1 ± 0.12 |
| 25 μM | 4.5 ± 0.22 | 5.2 ± 0.29 | 3.7 ± 0.32 | 3.8 ± 0.17 |
Values are an average of three independent experiments.
Fig. 6Motility assay on TSB/10 solidified with agar at 0.5 g l−1. Phase I and II cells (10 μl) cultivated with or without Cd were spotted on plates and 5 μl of CdCl2 1 M was deposited on a disk.